NewAmsterdam Pharma Company N.V.

8-K Other events Jul 24, 2026 8-K Director or officer change Jul 22, 2026 8-K Director or officer change; Shareholder vote results Jun 3, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Director or officer change Apr 24, 2026 8-K Regulation FD disclosure Mar 2, 2026 10-K Fiscal year ended 2025-12-31 Feb 18, 2026 8-K Results of operations (earnings release) Feb 18, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 9, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 5, 2025 8-K Regulation FD disclosure Sep 2, 2025 8-K Regulation FD disclosure; Other events Aug 18, 2025 8-K Entered a material agreement Aug 15, 2025 8-K Results of operations (earnings release) Aug 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Regulation FD disclosure; Other events Jul 30, 2025 8-K Director or officer change Jul 11, 2025 8-K Regulation FD disclosure Jun 11, 2025 8-K Regulation FD disclosure; Other events Jun 9, 2025 8-K Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Regulation FD disclosure; Other events May 7, 2025 8-K Director or officer change; Regulation FD disclosure Apr 17, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Regulation FD disclosure Jan 10, 2025 8-K Entered a material agreement; Regulation FD disclosure Dec 13, 2024 8-K Other events Dec 10, 2024 8-K Regulation FD disclosure Dec 10, 2024 8-K Regulation FD disclosure; Other events Nov 20, 2024 8-K Regulation FD disclosure; Other events Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 20-F/A Oct 28, 2024 8-K Previously issued financials not reliable Oct 18, 2024 8-K Other events Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024